Similar articles

• Reserpine and Raynaud's phenomenon.

  Gifford RW Jr. Gifford RW Jr. N Engl J Med. 1971 Jul 29;285(5):290-1. doi: 10.1056/NEJM197107292850513. N Engl J Med. 1971. PMID: 5090401 No abstract available.
• [Spasm and Raynaud's phenomenon].

  Fiessinger JN. Fiessinger JN. Ann Cardiol Angeiol (Paris). 1981 Mar-Apr;30(2):91-3. Ann Cardiol Angeiol (Paris). 1981. PMID: 7259052 French. No abstract available.
• [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease].

  Acevedo A, Palacios JM, López R, Palma F. Acevedo A, et al. Rev Med Chil. 1984 Jun;112(6):553-8. Rev Med Chil. 1984. PMID: 6515168 Spanish. No abstract available.
• Pharmacologic management of Raynaud's phenomenon.

  Day TW, Mendoza F. Day TW, et al. South Med J. 1984 Sep;77(9):1160-4. doi: 10.1097/00007611-198409000-00027. South Med J. 1984. PMID: 6385288 Review.
• Cold extremities: investigation and management of Raynaud's phenomenon.

  Farrington NK, Sutej PG. Farrington NK, et al. J South Orthop Assoc. 1996 Spring;5(1):37-45. J South Orthop Assoc. 1996. PMID: 8673588 Review.